Remeex(R) System Effectiveness in Male Patients with Stress Urinary Incontinence
Por:
Marquez-Sanchez, G, Padilla-Fernandez, B, Peran-Teruel, M, Navalon-Verdejo, P, Valverde-Martinez, S, Marquez-Sanchez, M, Flores-Fraile, J and Lorenzo-Gomez, M
Publicada:
1 may 2021
Categoría:
Medicine (miscellaneous)
Resumen:
Background: When conservative management fails, patients with stress urinary incontinence (SUI) are considered for surgical treatment. Simpler, more economical and less invasive surgical techniques, such as the Remeex(R) system, have been developed. Objectives: To analyze the objective effectiveness of the Remeex system in the treatment of male stress urinary incontinence. To study survival and complication rates of the Remeex(R) system in male SUI patients. Materials and methods: Prospective observational study between July 2015 and May 2020. Group A (n = 7; GA) patients with mild SUI. Group B (n = 22; GB) patients with moderate SUI. Group C (n = 18; GC) patients with severe SUI. Effectiveness was assessed by the number of patients achieving complete and partial dryness. Complete dryness was defined as patients using 0-1 safety pads per day; partial dryness as a >50% reduction in the number of pads used. Results were analyzed using descriptive statistics, Student's t-test. Chi2, Fisher's exact test, ANOVA, and multivariate analysis. Significance was set at p < 0.05. Results: Mean age 69.76 years, mean follow-up 33.52 months. Objective effectiveness was observed in 89.36% of patients with incontinence. The effectiveness was 85.71% in GA, 90.91% in GB and 88.89% in GC. There were no significant differences among groups (p = 1.0000). 34.04% of patients with an implant required at least one readjustment, while 66.00% did not require any. There were no significant differences among groups (p = 0.113) Chi2 = 4.352. 95.74% of implants remained in place by the end of follow-up. We observed complications in 17.02% of patients. Conclusions: Remeex(R) system is an effective and safe method for male stress urinary incontinence treatment, regardless of the severity of the incontinence, with high survival and low complication and removal rates. System readjustments are required in one-third of the cases.
Filiaciones:
Marquez-Sanchez, G:
Univ Salamanca, Dept Surg, Salamanca 37007, Spain
Padilla-Fernandez, B:
Univ La Laguna, Dept Surg, Sect Urol, Tenerife 38200, Spain
:
Univ Hosp Arnau Villanova, Dept Urol, Valencia 46015, Spain
Navalon-Verdejo, P:
Catholic Univ Valencia, Univ Hosp Casa Salud, Dept Urol, Valencia 46021, Spain
Valverde-Martinez, S:
Univ Salamanca, Dept Surg, Salamanca 37007, Spain
Inst Biomed Res Salamanca IBSAL, Renal Urol Multidisciplinary Res Grp GRUMUR, Salamanca 37007, Spain
Univ Hosp Avila, Dept Urol, Avila 05004, Spain
Marquez-Sanchez, M:
Inst Biomed Res Salamanca IBSAL, Renal Urol Multidisciplinary Res Grp GRUMUR, Salamanca 37007, Spain
Flores-Fraile, J:
Univ Salamanca, Dept Surg, Salamanca 37007, Spain
Lorenzo-Gomez, M:
Univ Salamanca, Dept Surg, Salamanca 37007, Spain
Inst Biomed Res Salamanca IBSAL, Renal Urol Multidisciplinary Res Grp GRUMUR, Salamanca 37007, Spain
Univ Hosp Salamanca, Dept Urol, Salamanca 37007, Spain
gold, Green Published
|